Temporal trend of benralizumab safety profile in severe asthma: a cumulative meta-analysis
L. Calzetta (Parma, Italy), J. Ora (Rome, Italy), F. Cavalli (Rome, Italy), R. Laitano (Rome, Italy), P. Rogliani (Rome, Italy)
Source: International Congress 2022 – Studies targeting IL-5 pathways in asthma
Session: Studies targeting IL-5 pathways in asthma
Session type: Thematic Poster
Number: 2122
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Calzetta (Parma, Italy), J. Ora (Rome, Italy), F. Cavalli (Rome, Italy), R. Laitano (Rome, Italy), P. Rogliani (Rome, Italy). Temporal trend of benralizumab safety profile in severe asthma: a cumulative meta-analysis. 2122
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|